Serum Inhibin B: A Direct And Precise Marker Of Ovarian Function
HALDER A, FAUZDAR A, GHOSH M, KUMAR A
Department of Reproductive Biology
All India Institute of Medical Sciences, New Delhi 110029.
Dr Ashutosh Halder, Associate Professor, Department of Reproductive Biology. All India Institute of Medical Sciences, New Delhi 110029 Tel: 011-26593304 , Fax: 011-26588663 Email: firstname.lastname@example.org
Background Inhibin B is a glycoprotein hormone produced mainly by granulosa cells of the ovary in early folliculogenesis. It selectively suppresses the secretion of pituitary FSH and has local paracrine actions in the gonads. Its measurement is useful for investigating female reproductive dysfunction. Objective The objective of this study was to examine serum levels of inhibin B in the assessment of ovarian function in patient with premature ovarian failure. Material & Method Serum from premature ovarian failure (n=34; group A), menopause (n=8; group B) and normally cycling fertile women (n=5; group C) was prospectively collected and stored at –80°C. Serum concentration of inhibin B was measured using specific solid phase sandwich ELISA. FSH level was measured using microparticle enzyme immuno assay (MEIA) for comparison. Independent sample t test was used to see the mean significance differences between groups. Results Inhibin B level was undetectable (i.e., <15pg/ml) in group A & B women. The mean value in group C women was 51.8pg/ml (range 26-75). Respective values of FSH were 78.8miu/ml (range 25-150), 100.7miu/ml (range 62-150) & 5.96miu/ml (range 4.2-7.9). Inhibin B level was significantly lower in group A & B than group C women (p<0.0001) whereas differences were insignificant between group A and B women. Similarly FSH level was significantly higher in group A & B than group C women (p<0.0001). We found wide variation in FSH level in group A women. In 5 women FSH level was below 40miu/ml and was related to exogenous estrogen intake more than 3 months of blood sampling. Conclusion This study demonstrated that inhibin B is a better predictor for ovarian failure than FSH and uninfluenced by exogenous estrogen intake (if taken >3 months before).
: Premature Ovarian Failure; Inhibin B & FSH
cite this article :
HALDER A, FAUZDAR A, GHOSH M, KUMAR A. SERUM INHIBIN B: A DIRECT AND PRECISE MARKER OF OVARIAN FUNCTION. Journal of Clinical and Diagnostic Research [serial online] 2007 June [cited: 2013 Jun 19 ]; 1:131-137. Available from http://www.jcdr.net/back_issues.asp?issn=0973-709x&year=2007&month=June&volume=1&issue=3&page=131-137&id=69
Inhibin B is a heterodimeric glycoprotein consisting one α-subunit and one βB subunit (1). Inhibin B expression and secretion in women is positively correlated with granulosa cell function, oocyte number & oogenesis (2),(3) and negatively correlated with FSH (4),(5),(6). It is regarded as a serum marker of oogenesis and may offer an improved diagnosis of ovarian function (7),(8).(9). Human FSH is a glycoprotein and consist of α and β subunits. In the workup of female infertility, FSH is the classical endocrine parameter to discriminate between ovarian impairment and other disorders. Several studies confirm that FSH level is a valuable marker of oogenesis (10),(11),(12),(13),(14). The current study is designed to examine possible role of inhibin B as a predictor of ovarian reserve in comparison with FSH.
Material and Methods
Subjects The cases were selected from Department of Reproductive Biology, AIIMS between 2002 & 2003 while they were referred by various hospitals including our own for reproductive hormone analysis for infertility, menstrual irregularity or secondary amenorrhoea. Thirty four premature ovarian failure (POF) women (vide (Table/Fig 1) for diagnostic criteria) were selected for the study from 214 women referred. Suspected POF cases were interviewed in detail for medical, surgical & treatment (particularly exogenous estrogen & cytotoxic chemotherapy) history and examined clinically (general & systemic) to exclude any gross [Table/fig 1]underlying disease as per proforma. Most of the cases were investigated extensively outside (including ultrasonography, reproductive hormones, haemogram, biochemistry, TSH, ANA, etc) before attending our department. All related information was obtained in detail. Cases were selected as per criteria given in (Table/Fig 1). No one had history of autoimmune disease, surgical removal of gonads, radiotherapy or chemotherapy. All the cases were followed up for at least one year. Five known normally cycling fertile women (group C) and eight menopausal women (group B) were included for comparison. Blood sampling from normally cycling fertile women was collected on day 2 or 3 of menstrual cycle. Postmenopausal women were selected from another ongoing project of the department. None of the cases had exogenous estrogen intake for 3 months before blood sampling although most were treated by estrogen in past (more than 3 months ago). Informed consent was obtained before blood sampling. All blood sampling were in fasting state. Serum was isolated after centrifugation and stored at -800C for 1 to 10 months before inhibin B & FSH assay. Hemolyzed and bilirubin containing samples were discarded from the study.
Assays Serum concentration of FSH was measured using highly specific microparticle enzyme immuno assay (MEIA) using AxSYM automated immunoassay system (Abbott Laboratories, USA). Inter and intra- assay coefficients of variation was <3%, cross reactivity with TSH, LH & hCG was <1% and detection limit was <0.4 mIU/ml. Serum concentration of Inhibin B was measured using a commercially available solid-phase sandwich enzyme-linked immunosorbent assay (ELISA) specific for the dimeric inhibin-B (Oxford Bio-Innovation Ltd. Oxford, UK via Serotec) (15),(16). The first antibody is directed to the βB-subunit and the second antibody to the α-subunit and conjugated to alkaline phosphatase. The assay had a cross-reactivity of 0.1% with activin and ~1% with inhibin A. Assay sensitivity/detection limit was 15 pg/ml and the inter/intra-plate coefficients of variation was <7%. Before ELISA samples were pretreated with detergent (SDS), heated to 100ºC and exposed to hydrogen peroxide to enhance sensitivity as well as specificity. Control and known standard (1000, 500, 250, 125, 62.5, 31.25 & 15.6) were used for the study. Patients with inhibin B concentrations below detection limit i.e., 15 pg were assigned as undetectable. All the samples were tested in duplicate. Microtitre plates were pre-coated with a monoclonal antibody to the beta-B subunit of inhibin. Samples (including control & standard) were incubated in the wells so that the antigen binds to the immobilized antibody via its βB subunit. Following washing a detection antibody was added. This was a monoclonal antibody specific for α subunit of inhibin coupled to alkaline phosphatase. Any unreacted material is then removed by washing before detection of alkaline phosphatase using a sensitive amplified substrate. This resulted in a red reaction product with color intensity proportionate to the concentration of dimeric inhibin B present in<
The mean (±SD) age and plasma levels of FSH & inhibin B of group A, B & C are shown in (Table/Fig 2). The age difference was not significant statistically (p = 0.95) between group A & C. Plasma FSH level was elevated in group A & B in contrast to group C women (P < 0.0001). Women in group A & B had undetectable (≤15 pg/ml) level of serum inhibin B whereas the mean level in group C was 51.8pg/ml. The difference was statistically significant (p <0.0001). Level of inhibin B in group A was no different than in group B. Plasma FSH of group A/B and group C was inversely correlated with plasma inhibin B. There was not a single case with normal FSH/inhibin B in group A & B however there were five case in group A with non-menopausal (<40miu/ml) FSH. All had history of exogenous estrogen intake preceding 3 months of blood sampling (Table/Fig 3). Interphase FISH with chromosome X centromeric probe was carried out in all cases of POF (group A). All excepting 2 were disomic for chromosome X (normal). Two cases of chromosome X mosaicism (XX/XXX) were detected however, frequency of trisomic (XXX) cell line was below 10%.
In current society, the desire of women to reproduce in later years leads to an increase incidence of infertility. Infertility workup and treatment is frequently time consuming, expensive and unsuccessful leading to economical & psychosocial difficulties. Hence, evaluation of ovarian status to identify women who has a chance of becoming pregnant before initiating expensive treatment becomes more important for proper prediction & counseling. This may decrease anxiety as well as marital disharmony. Ovarian status can be screened using various tests. FSH, estradiol, ovarian volume, antral follicle count, ovarian biopsy, clomiphene citrate challenge test or gonadotropin analogue stimulation test are commonly used. The clomiphene citrate challenge test is widely accepted method of testing ovarian reserve (18),(19),(20),(21), however, it requires few days to perform and multiple blood sampling. The gonadotropins analogue stimulation test is based on concentrations of FSH, estradiol and LH before and after GnRH analogue administration (22). Its limitations are expense, need for injections and repeated blood samplings in addition to limited ability to differentiate normal from reduced ovarian reserve (23). Hence there is a need for alternative simple test. Simple tests for ovarian reserve are ultrasonography (10),(24),(25) and FSH (11). However, they have their diagnostic limitations as ovulation may be seen in premature ovarian failuredespite high FSH (4) and subjectiveness of ovarian ultrasonography. Ovarian biopsy (26),(27) although reliable is invasive procedure. Hence there is a clear need for noninvasive, direct and precise marker of ovarian reserve. The identification of a parameter that can discriminate between complete absence of germ cells in the ovary and less severe disturbances of ova production would be of considerable prognostic value for assessment of female infertility. Inhibin B & AMH, which are direct product of the granulosa cells, may be more accurate in this regard. Both AMH and inhibin B are produced by the granulosa cells of preantral and small antral follicles of ovary during early folliculogenesis. Since the number of ovarian follicles declines with increasing age, AMH & inhibin B levels may be used as a direct & precise marker for ovarian ageing. Reports claim that inhibin B (2),(7),(8),(12),(28),(29),(30) and antimullerian hormone (10),(31),(32) are better markers of ovarian function.
This study was aimed to find out role of Inhibin B in assessment of gonadal function in premature ovarian failure women and compared with FSH. This cohort of patient was after exclusion of those suffering from overt/diagnosed medical disease or on medication. None of POF cases resumed spontaneous menstruation or conceived in one year (some up to 2 years)follow-up. The FSH rise in older women has been well documented (33),(34) and commonly utilized test for ovarian reserve. FSH level of ≥40miu/ml in two occasions at interval of 1 or more month/s is indicative of ovarian failure (35). Serum FSH levels was high in all POF & menopausal women in our study however there were 5 cases of POF with below menopausal (40miu/ml) FSH. Previous studies demonstrated that POF women with amenorrhea for less than 3 months and low
We conclude that undetectable inhibin B and high FSH constitute markers of ovarian failure and measurements can be a useful non-invasive one step tool for management as well as counseling of POF women who are seeking infertility treatment.
Conflict of Interest: None declared
Inhibin B is a better predictor for ovarian function than FSH
The authors thank Indian Council of Medical Research, India for financial supported through the research grant for “Role of Cytokines on Premature Ovarian Failure.”
Chada M, Prusa R, Bronsky J, Pechova M, Kotaska K, Lisa L. Inhibin B, follicle stimulating hormone, luteinizing hormone, and estradiol and their relationship to the regulation of follicle development in girls during childhood and puberty. Physiol Res 2003; 52: 341-346.
Welt CK, Hall JE, Adams JM, Taylor AE. Relationship of estradiol and inhibin to the follicle-stimulating hormone variability in hypergonadotropic hypogonadism or premature ovarian failure. J Clin Endocrinol Metab 2005; 90: 826-830.
Klein NA, Houmard BS, Hansen KR, Woodruff TK, Sluss PM, Bremner WJ, et al. Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab 2004; 89: 2977-2981.
van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005; 83: 979-987.